Dr Reddy S Laboratories
-
{
- All
- News
- Videos
-
Cyber Fraud Targeting Drugmaker Dr Reddy's Busted, Rs 2.16 Crore Recovered
Group Pharmaceuticals was due to receive a payment of Rs 2.16 crore from Dr. Reddy's Laboratories. However, hackers gained access to their emails and diverted funds.
-
Dr Reddy's Open To Making Pfizer Covid Pill
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
-
When, Where And How Much - Your Questions About Sputnik V Answered
The first doses of Russia's Sputnik V COVID-19 vaccine were given out in India on Friday in a soft launch that is expected to be scaled up in the coming days.
-
Sputnik V (Imported) To Cost Rs 995 Per Shot, First Dose Administered
An imported dose of Russia's Sputnik V vaccine against coronavirus will cost Rs. 995.40 in India, Dr Reddy's Laboratories, which is manufacturing the vaccine in India, said today.
-
Expert Panel Seeks Additional Data From Dr Reddy's Laboratories Over Sputnik V Vaccine
An expert panel of India's central drug authority has sought additional data and information from Dr Reddy's Laboratories, which has sought emergency use authorisation for Russian COVID-19 vaccine Sputnik V
-
On Request For Sputnik 5 Vaccine Approval, Panel Seeks More Data: Sources
The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.
-
Dr Reddy's Aims To Launch Russia's Sputnik V Vaccine For Emergency Use In March
Dr Reddy's Laboratories, which is conducting Phase 3 trials of Russia's COVID-19 vaccine Sputnik V, believes the jab is expected to be launched in India through Emergency Use Authorisation, a senior official of the city-based drug maker said on Friday.
-
Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
-
Trials For Russia's Vaccine To Start In India In Next Few Weeks: Official
Dr Reddy's Laboratories Ltd could begin late-stage clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the drugmaker said.
-
This Country Owes Indian Firms A Lot Of Money. It May Pay With Oil.
Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies.
-
'Withdrawl of Tax Exemption to Negatively Impact Innovation'
Withdrawal of tax exemption for research and development is likely to negatively impact India's innovation efforts, pharma major Dr Reddy's Laboratories said today.
-
Cyber Fraud Targeting Drugmaker Dr Reddy's Busted, Rs 2.16 Crore Recovered
Group Pharmaceuticals was due to receive a payment of Rs 2.16 crore from Dr. Reddy's Laboratories. However, hackers gained access to their emails and diverted funds.
-
Dr Reddy's Open To Making Pfizer Covid Pill
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
-
When, Where And How Much - Your Questions About Sputnik V Answered
The first doses of Russia's Sputnik V COVID-19 vaccine were given out in India on Friday in a soft launch that is expected to be scaled up in the coming days.
-
Sputnik V (Imported) To Cost Rs 995 Per Shot, First Dose Administered
An imported dose of Russia's Sputnik V vaccine against coronavirus will cost Rs. 995.40 in India, Dr Reddy's Laboratories, which is manufacturing the vaccine in India, said today.
-
Expert Panel Seeks Additional Data From Dr Reddy's Laboratories Over Sputnik V Vaccine
An expert panel of India's central drug authority has sought additional data and information from Dr Reddy's Laboratories, which has sought emergency use authorisation for Russian COVID-19 vaccine Sputnik V
-
On Request For Sputnik 5 Vaccine Approval, Panel Seeks More Data: Sources
The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.
-
Dr Reddy's Aims To Launch Russia's Sputnik V Vaccine For Emergency Use In March
Dr Reddy's Laboratories, which is conducting Phase 3 trials of Russia's COVID-19 vaccine Sputnik V, believes the jab is expected to be launched in India through Emergency Use Authorisation, a senior official of the city-based drug maker said on Friday.
-
Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
-
Trials For Russia's Vaccine To Start In India In Next Few Weeks: Official
Dr Reddy's Laboratories Ltd could begin late-stage clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the drugmaker said.
-
This Country Owes Indian Firms A Lot Of Money. It May Pay With Oil.
Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies.
-
'Withdrawl of Tax Exemption to Negatively Impact Innovation'
Withdrawal of tax exemption for research and development is likely to negatively impact India's innovation efforts, pharma major Dr Reddy's Laboratories said today.
